Changes in Serum Cytokines by Week 24 Correlate with Long-Term Efficacy of Guselkumab Through Two Years in Bio-Naive Adults with PsA

Siebert S, Schett G, Raychaudhuri SP, Guma M, Chen W, Gao S, Chakravarty S, Shawi M, Rahman P (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Arthritis and Rheumatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 4168-4170

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

University of California Davis (UCDAVIS) US United States (USA) (US) University of Glasgow GB United Kingdom (GB) Memorial University of Newfoundland (MUN) CA Canada (CA) University of California, San Diego US United States (USA) (US) Janssen Pharmaceutica NV BE Belgium (BE) Johnson & Johnson Services, Inc. US United States (USA) (US) Drexel University US United States (USA) (US)

How to cite

APA:

Siebert, S., Schett, G., Raychaudhuri, S.P., Guma, M., Chen, W., Gao, S.,... Rahman, P. (2022). Changes in Serum Cytokines by Week 24 Correlate with Long-Term Efficacy of Guselkumab Through Two Years in Bio-Naive Adults with PsA. In ARTHRITIS & RHEUMATOLOGY (pp. 4168-4170). HOBOKEN: WILEY.

MLA:

Siebert, Stefan, et al. "Changes in Serum Cytokines by Week 24 Correlate with Long-Term Efficacy of Guselkumab Through Two Years in Bio-Naive Adults with PsA." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2022. 4168-4170.

BibTeX: Download